Tele-Ergonomics Assessment Methodologies Study

Abstract

The most significant problem has been with IRB approval. This minimal risk proposal was submitted to MRMC IRB for approval as CHPPM does not have an IRB. We have used the. MRMC IRB as our primary IRB in the past and I had assumed that the MRMC IRB approval was all that would be required; however, after the proposal had been reviewed, corrected and re-submitted, I was informed that the proposal would need to be submitted to each of the IRBs for the target bases. Since time was a concern, it was decided to re-target bases under one IRB rather than submit the proposal to four different IRBs. The target bases were changed to Fort Drum, Fort Eustis, Fort Knox, Fort Lee and Fort Bragg. All of these bases fall under the WRAMC IRB. The proposal has received WRAMC IRB approval and has been sent for final MRMC approval. Unfortunately, this time delay could have been avoided if I had realized that the MRMC approval alone would not suffice. The WRAMC IRB approval stipulates that statements from the installation commanders approving and supporting the project be submitted before the data collection starts. Fort Lee has submitted this statement and the POCs at the other installations are conducting briefings and staffing information papers to get these statements. We anticipate the final approval from MRMC within the next week.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
May 01, 2000
Accession Number
ADA388933

Entities

People

  • Mary Lopez

Organizations

  • United States Army Center for Health Promotion and Preventive Medicine

Tags

Communities of Interest

  • Biomedical
  • Human Systems

DTIC Thesaurus Topics

  • Abstracts
  • Biomedical Research
  • Data Analysis
  • Education
  • Electronic Mail
  • Environmental Health
  • Field Tests
  • Health Care
  • Human Factors Engineering
  • Information Operations
  • Instructions
  • Life Cycles
  • Maryland
  • Targets
  • Technicians
  • Test And Evaluation
  • Training

Readers

  • Clinical Trial Research.